New 'Living Drug' tested in fight against tough cancers
Disease control
Completed
This early-stage study tested a new type of cell therapy for people with advanced stomach or pancreatic cancer that has stopped responding to standard treatments. Doctors gave 10 patients immune cells from donated cord blood that were engineered to attack a specific protein found…
Phase: PHASE1 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC